908 Devices Inc. (MASS) Key Metrics

NASDAQ: MASSValuation, returns, debt and efficiency ratios over 8 years.

MASS valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$465.4M
Enterprise value
$355.4M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
7.6
10-yr median 5.1
Price / book
3.6
10-yr median 1.4
EV / EBITDA
—
Dividend yield
—
Beta
0.62

MASS key metrics, 2018–2025

Fiscal year ended December 31, 2025 · U.S. dollars

MASS valuation Price multiples at each fiscal year-end price.

Price / sales+189.2%
3.6
2025 · hover or tap a bar for each year
2021: 17.12022: 5.1 (−70.1%)2023: 7.2 (+40.6%)2024: 1.3 (−82.5%)2025: 3.6 (+189.2%)
20182025
Price / book+117.3%
1.4
2025 · hover or tap a bar for each year
2021: 3.42022: 1.3 (−62.6%)2023: 2.2 (+73.6%)2024: 0.7 (−70.1%)2025: 1.4 (+117.3%)
20182025
Free cash flow yield+29.1 pts
−12.1%
2025 · hover or tap a bar for each year
2021: −4.1%2022: −9.6% (−5.5 pts)2023: −7.5% (+2.1 pts)2024: −41.1% (−33.7 pts)2025: −12.1% (+29.1 pts)
20182025

MASS valuation history

Fiscal year-endToday8-year median

MASS returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

MASS debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

MASS cash returned to shareholders

DividendsBuybacksFree cash flow

MASS price vs earnings per share

Share price at year-endEPS (right axis)

MASS key metrics

2018–2025
908 Devices Inc. key metrics by fiscal year
20252024202320222021202020192018
Valuation
Market capitalization$204.3M$75.0M$361.7M$240.0M$723.3M———
Enterprise value$108.1M$12.0M$222.0M$71.1M$520.0M———
Price / sales3.61.37.25.117.1———
Price / book1.40.72.21.33.4———
EV / sales1.90.24.41.512.3———
Earnings yield−17.9%−96.3%−10.1%−13.2%−3.1%———
Free cash flow yield−12.1%−41.1%−7.5%−9.6%−4.1%———
Dividend yield———0.1%————
Shareholder yield (dividends + buybacks)——0.2%0.2%0.0%———
Share price at fiscal year-end$5.25$2.20$11.22$7.62$25.87$56.95——
Per share
Revenue per share$1.44$1.75$1.56$1.49$1.51———
Earnings per share−$0.94−$2.12−$1.13−$1.01−$0.79———
Operating cash flow per share−$0.61−$0.89−$0.78−$0.66−$1.04———
Free cash flow per share−$0.63−$0.91−$0.84−$0.73−$1.07———
Cash per share$2.90$2.04$4.52$5.98$8.01———
Book value per share$3.69$3.36$5.13$6.05$7.68———
Tangible book value per share$2.76$2.03$4.57$5.46$7.68———
Dividends per share———$0.01————
Capex per share$0.02$0.02$0.06$0.06$0.03———
Debt per share$0.43$0.19$0.18$0.62$0.75———
Shares outstanding38.9M34.1M32.2M31.5M28.0M———
Change in shares outstanding+14.2%+5.7%+2.4%+12.6%————
Returns & profitability
Return on equity (ROE)−28.4%−51.6%−20.4%−15.7%−12.5%−33.8%——
Return on invested capital (ROIC)−38.6%−156.7%−142.4%−169.1%−267.1%———
Return on assets (ROA)−21.0%−39.8%−16.3%−12.6%−10.1%−11.8%−40.9%−27.2%
Return on tangible assets−23.8%−63.2%−19.7%−14.2%−8.5%−7.2%−35.5%−27.2%
Free cash flow margin−43.9%−51.7%−54.0%−49.0%−70.7%15.3%−63.4%−43.6%
Financial health
Total debt$16.7M$6.6M$5.9M$19.5M$20.9M$21.9M$22.8M$17.9M
Cash & short-term investments$113.0M$69.6M$145.7M$188.4M$224.1M$159.2M$17.9M$7.1M
Net debt−$96.3M−$63.0M−$139.7M−$168.9M−$203.2M−$137.4M$4.9M$10.9M
Debt / equity0.120.060.040.100.100.16——
Debt / assets0.090.040.030.080.080.120.610.65
Current ratio4.244.107.7111.2217.0515.784.723.61
Quick ratio3.863.457.0410.5616.5115.363.862.87
Interest coverage——-212.7-274.3-45.4-6.0-7.9-5.6
Working capital$110.5M$77.9M$151.2M$196.4M$238.1M$160.1M$22.5M$12.4M
Invested capital$47.4M$51.6M$25.8M$21.7M$11.4M$1.7M−$58.3M−$39.3M
Tangible asset value$107.3M$69.3M$147.3M$172.1M$214.6M$139.0M−$63.2M−$50.2M
Net current asset value$98.2M$58.2M$136.3M$163.6M$206.6M$131.2M−$72.2M−$60.7M
Graham net-net per share$2.10$1.24$3.80$4.77$6.94———
Capital allocation
Dividends paid———$262,000————
Share buybacks (net)——$776,000$262,000$0———
Capex / revenue1.7%1.0%4.1%4.4%1.7%0.0%2.2%3.3%
Capex / operating cash flow—————0.2%——
Capex / depreciation0.210.130.861.270.800.010.440.81
Stock-based compensation / revenue17.5%19.7%19.5%15.4%5.9%2.0%1.5%1.0%
R&D / revenue24.6%42.8%43.6%37.4%31.0%30.6%50.0%43.2%
SG&A / revenue68.6%89.9%92.0%93.7%76.4%46.5%62.8%42.2%
Efficiency
Days sales outstanding77.866.269.1103.6101.280.8115.9104.9
Days of inventory on hand181.0191.1201.1179.0120.1149.5162.7133.1
Days payables outstanding65.120.019.024.322.824.122.724.4
Cash conversion cycle (days)193.7237.3251.3258.4198.4206.2255.9213.6
Receivables turnover4.695.525.283.523.614.523.153.48
Payables turnover5.6118.2619.2515.0515.9815.1416.0914.98
Inventory turnover2.021.911.812.043.042.442.242.74
Asset turnover0.320.330.230.190.190.250.550.79
Average receivables$12.0M$10.8M$9.5M$13.3M$11.7M$6.0M$5.7M$6.3M
Average payables$5.2M$1.6M$1.3M$1.4M$1.2M$790,500$611,000$645,000
Average inventory$14.6M$15.6M$13.7M$10.2M$6.2M$4.9M$4.4M$3.5M
Intangibles / total assets19.2%28.4%9.0%7.6%0.0%0.0%0.0%0.0%

Computed from MASS's annual financial statements (latest annual report filed March 9, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

MASS valuation and financial ratios

908 Devices earned a return on equity of −28.4% and a return on invested capital of −38.6% in fiscal 2025. It ended the year with $16.7 million of debt and $113.0 million in cash and short-term investments, a net cash position of $96.3 million.

See the MASS income statement, the MASS chart for price history, or the MASS stock overview for the latest quote and news.

MASS key metrics FAQ

What is 908 Devices's return on equity?

908 Devices's return on equity (ROE) was −28.4% in fiscal 2025: net income of -$36.6 million on average shareholders' equity of $129.1 million.

What is 908 Devices's ROIC?

908 Devices's return on invested capital was −38.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does 908 Devices have?

908 Devices had total debt of $16.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.12 and more cash than debt.

What is 908 Devices's free cash flow yield?

908 Devices generated -$24.6 million of free cash flow in fiscal 2025, a free cash flow yield of −12.1% on its market value at year-end ($204.3 million).

What is 908 Devices's current ratio?

908 Devices's current ratio was 4.24 at the end of fiscal 2025: current assets were 4.24 times current liabilities.

Medical Devices key metrics